During the last three months, 5 analysts shared their evaluations of Sage Therapeutics (NASDAQ:SAGE), revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 1 | 4 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 2 | 0 | 0 |
2M Ago | 0 | 0 | 2 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $26.2, with a high estimate of $29.00 and a low estimate of $22.00. Surpassing the previous average price target of $22.50, the current average has increased by 16.44%.
Interpreting Analyst Ratings: A Closer Look
The standing of Sage Therapeutics among financial experts is revealed through an in-depth...
Login or create a forever free account to read this news
Sign up/Log in